Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone lotion - Acrux

Drug Profile

Testosterone lotion - Acrux

Alternative Names: Axeron; Axiron; LY-900011; Testosterone MD-Lotion; Testosterone metered-dose lotion - Acrux

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Acrux
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypogonadism

Most Recent Events

  • 01 Apr 2015 Eli Lilly completes a phase III trial for Hypogonadism in USA, Argentina, Brazil, Germany, Italy, South Korea, Spain and the United Kingdom (NCT01816295; EudraCT 2012-004866-16)
  • 23 Jan 2015 Biomarkers information updated
  • 08 Jan 2015 Registered for Hypogonadism in Austria, Denmark, Finland, Norway and Sweden (Transdermal) through decentralised procedure (EMA website, April 2015)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top